Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Del Poeta

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Leukemia Research|July 1, 1996
High-dose chemotherapy in adult acute myeloid leukemia: rationale and resultsR Stasi, A Venditti, G Del Poeta, et al.
Blood|March 15, 1994
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0)R Stasi, G Del Poeta, A Venditti, et al.
Leukemia|December 1, 1995
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotypeA Giuliani, P Vernole, S D'Atri, et al.
Cancer Genetics and Cytogenetics|March 25, 2000
A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0)M C Cox, A Scanzani, G Del Poeta, et al.
Current Cancer Drug Targets|June 13, 2009
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to nutlin-3 induces a characteristic gene expression profile, which correlates with nutlin-3-mediated cytotoxicityG Zauli, M G di Iasio, P Secchiero, et al.
Leukemia|January 13, 2006
CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevanceA Zucchetto, R Bomben, M Dal Bo, et al.
Leukemia|June 10, 2005
Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?R Bomben, M Dal Bo, A Zucchetto, et al.
Annals of Hematology|September 1, 1996
FISH analysis for CML monitoring?M C Froncillo, L Maffei, M Cantonetti, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaR Stasi, G Del Poeta, M Masi, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Leukemia Research|July 1, 1996
High-dose chemotherapy in adult acute myeloid leukemia: rationale and resultsR Stasi, A Venditti, G Del Poeta, et al.
Blood|March 15, 1994
Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0)R Stasi, G Del Poeta, A Venditti, et al.
Leukemia|December 1, 1995
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotypeA Giuliani, P Vernole, S D'Atri, et al.
Cancer Genetics and Cytogenetics|March 25, 2000
A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0)M C Cox, A Scanzani, G Del Poeta, et al.
Current Cancer Drug Targets|June 13, 2009
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to nutlin-3 induces a characteristic gene expression profile, which correlates with nutlin-3-mediated cytotoxicityG Zauli, M G di Iasio, P Secchiero, et al.
Leukemia|January 13, 2006
CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevanceA Zucchetto, R Bomben, M Dal Bo, et al.
Leukemia|June 10, 2005
Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?R Bomben, M Dal Bo, A Zucchetto, et al.
Annals of Hematology|September 1, 1996
FISH analysis for CML monitoring?M C Froncillo, L Maffei, M Cantonetti, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaR Stasi, G Del Poeta, M Masi, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
Pageof 9